v3.26.3
EQUITY (Tables)
12 Months Ended
Jun. 30, 2026
Equity [Abstract]  
SCHEDULE OF WARRANTS OUTSTANDING

The remaining outstanding warrants as of June 30, 2026 are:

   

   Warrants Outstanding   Exercise Price   Expiration Date
            
November 2021 SPA   60,125   $4.40   November 2026
November 2021 SPA   21,125   $4.40   May 2027
May 2026 SPA   524,147   $4.40   November 2033
May 2026 SPA (Prefunded Warrants)   341,530   $4.40   No Expiry
Total   946,927         
SCHEDULE OF STOCK OPTION FAIR VALUE ASSUMPTION

Stock options have been recorded at their fair value. The Black-Scholes option-pricing model assumptions used to value the issuance of stock options under the Plan for the specific periods below are noted in the following table:

      

   2026   2025 
   For the Years Ended
June 30,
 
   2026   2025 
Weighted average expected terms (in years)   5.6    5.5 
Weighted average expected volatility   101.0%   125.6%
Weighted average risk-free interest rate   4.0%   4.3%
Expected dividend yield   0.0%   0.0%
SUMMARY OF STOCK OPTION ACTIVITY

The following is a summary of the Company’s stock option activity for the years ended June 30, 2026 and 2025:

       

       Weighted Average     
           Remaining     
       Exercise   Contractual   Intrinsic 
   Options   Price   Term (Yrs)   Value 
Outstanding at July 1, 2025   345,775   $26.96    5.6   $- 
Options Granted   70,026    10.48    7.3    130,053 
Options Exercised   -    -    0.0    - 
Options Forfeited / Cancelled   (91,590)   27.28    0.4    - 
Outstanding at June 30, 2026   324,211   $23.36    4.4   $130,053 
Exercisable at June 30, 2026   292,132   $24.32    3.9   $100,609 

 

       Weighted Average     
           Remaining     
       Exercise   Contractual   Intrinsic 
   Options   Price   Term (Yrs)   Value 
Outstanding at July 1, 2024   455,484   $31.60    6.5   $- 
Options Granted   68,225    19.04    9.4    16,300 
Options Exercised   (4,450)   20.00    1.8    - 
Options Forfeited / Cancelled   (173,484)   36.24    6.8    9,942 
Outstanding at June 30, 2025   345,775   $26.96    5.6   $- 
Exercisable at June 30, 2025   231,266   $28.64    4.6   $- 
SCHEDULE OF STOCK OPTION BASED EXPENSE

The Company’s stock option-based expense for the years months ended June, 2026 and 2025 consisted of the following:

       

   2026   2025 
   For the Years Ended 
   June 30 
   2026   2025 
Stock option-based expense:          
Research and development expenses  $107,353   $107,563 
General and administrative expenses   324,572    254,011 
Sales and marketing expenses   18,326    31,100 
Board option expense   290,458    229,389 
Total  $740,709   $622,063